Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes.

1 Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan 2 Division of Metabolism and Biosystemic Science, Asahikawa Medical College, Hokkaido, Japan 3 Division of Nephrology and Hypertension, Diabetes Center, Tokyo Women's Medical University School of Medicine, Tokyo, Japan 4 Department of Endocrinology, Diabetes and Metabolism, Kitasato University School of Medicine, Kanagawa, Japan Division of Nephrology, Tohoku University Graduate Medical School, Miyagi, Japan 6 Department of Medicine, Diabetes Center, Tokyo Women's Medical University School of Medicine, Tokyo, Japan 7 Department of Medicine, Medical School, Juntendo University, Tokyo, Japan 8 Division of Biostatistics, School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan 9 Division of Endocrinology and Diabetes, Department of Medicine, Saitama Medical School, Saitama, Japan